LauraSola Uruguay

Day 1 - Sunday April 14, 2024

Time	Session

03:00 pm 04:00 pm	Kidney Health for All - Advancing Equitable Access to Care and Optimal Medication Practice: WKD Session DinaAbdellatif Chairperson dina.abdellatif@gmail.comCairo University HospitalEgypt VassiliosLiakopoulos Chairperson liakopul@otenet.gr2nd Department of Nephrology, AHEPA Hospital, Medical School, Aristotle University of Thesalloniki, GreeceGreece Building Bridges to Reduce Fragmentation of Kidney Care RicardoCorrea Rotter Speaker correarotter@gmail.comInstituto Nacional de Ciencias Médicas y Nutrición Salvador ZubiránMexico Transforming Kidney Care Through Equitable Breakthrough Therapies KatherineTuttle Speaker Katherine.Tuttle@providence.orgUniversity of Washington, Department of NephrologyUnited States Closing the Gaps: Implementing Best Practices for CKD Care Worldwide ValerieLuyckx Speaker valerie.luyckx@uzh.chUniversity of ZurichSwitzerland A Patient's Perspective on Gaps in Care MariaSeijas Speaker Mseijas@ifc.orgCFAArgentina Q and A Hall C1

Time

Session

03:00 pm

04:00 pm

Kidney Health for All - Advancing Equitable Access to Care and Optimal Medication Practice: WKD Session

DinaAbdellatif Chairperson dina.abdellatif@gmail.comCairo University HospitalEgypt

VassiliosLiakopoulos Chairperson liakopul@otenet.gr2nd Department of Nephrology, AHEPA Hospital, Medical School, Aristotle University of Thesalloniki, GreeceGreece

Building Bridges to Reduce Fragmentation of Kidney Care

RicardoCorrea Rotter Speaker correarotter@gmail.comInstituto Nacional de Ciencias Médicas y Nutrición Salvador ZubiránMexico
Transforming Kidney Care Through Equitable Breakthrough Therapies

KatherineTuttle Speaker Katherine.Tuttle@providence.orgUniversity of Washington, Department of NephrologyUnited States
Closing the Gaps: Implementing Best Practices for CKD Care Worldwide

ValerieLuyckx Speaker valerie.luyckx@uzh.chUniversity of ZurichSwitzerland
A Patient's Perspective on Gaps in Care

MariaSeijas Speaker Mseijas@ifc.orgCFAArgentina
Q and A

Hall C1

Day 2 - Monday April 15, 2024

Time	Session

09:00 am 10:30 am	Insights From Understanding Heterogeneous Trajectories to Kidney Failure FacundoDaminato Chairperson fmdaminato@hotmail.comArgentina PietroRavani Chairperson pravani@ucalgary.caUniversity of CalgaryCanada Magdalena Madero Chairperson madero.magdalena@gmail.comChief of Nephrology, Instituto Nacional de CardiolMexico Non-neoplastic Lesions in Nephrectomy Samples: Implications for Kidney Function JairMunoz Mendoza Speaker JMMendoza@med.miami.eduUniversity of MiamiUnited States Understanding the Heterogeneous Trajectory of CKD MorganGrams Speaker morgan.grams@nyulangone.orgNew York UniversityUnited States Review of Medical Therapies Proven to Delay CKD Progression DoreenZhu Speaker doreen.zhu@ndph.ox.ac.ukUniversity of OxfordUnited Kingdom Impact of Obesity and Novel Treatment Strategies on CKD Progression PeterRossing Speaker peter.rossing@regionh.dkSteno Diabetes Center Copenhagen Denmark Q and A Hall C4
12:00 pm 01:00 pm	Chronic Kidney Disease and the Global Public Health Agenda MonicaWang Spotlight Speaker monica.wang@nature.comNature Reviews of NephrologyUnited Kingdom VivekanandJha Spotlight Speaker vjha@georgeinstitute.org.inGeorge Institute for Global Health IndiaIndia Spotlight Stage 1 (exhibition hall)
12:15 pm 01:15 pm	KDIGO 2024 Anemia Guideline: Case-based Illustrations: ISN-KDIGO Joint Session Carlos LuisBlanco Chairperson clbblanco@yahoo.com.arCARLOS LUIS BLANCO, ISN EMERIT MEMBER, ARGENTINA Argentina MarcelloTonelli Chairperson cello@ucalgary.caSenior Associate Dean (Clinical Research), CummingCanada TalerngsakKanjanabuch Chairperson golfnephro@hotmail.comThailand KDIGO 2024 Anemia CKD Guideline: Overview on Methodology and Key Guidance EviNagler Speaker evi.nagler@ugent.beNephrology Department, Ghent University Hospital, Belgium Practical Guideline Applications for Patients with Anemia CKD Not on Dialysis JoséA. Moura-Neto Speaker jamouraneto@hotmail.comBrazilian Society of NephrologyBrazil Practical Guideline Applications for Select Patients With Anemia: Dialysis, Kidney Transplant Recipients, and Children with CKD MarcelloTonelli Speaker cello@ucalgary.caSenior Associate Dean (Clinical Research), CummingCanada Q and A Hall E
03:00 pm 04:00 pm	Stewardship and Forward Planning in Stage Four CKD. ISN-KSN Joint Session Ana ElizabethFigueiredo Chairperson anaef@pucrs.brPontifícia Universidade Católica do Rio Grande do Brazil AnaCusumano Chairperson anacusumano@gmail.com.arCEMIC University Institute School of Health SciencesArgentina Sung GyunKim Chairperson imnksk@gmail.comHallym University Sacred Heart HospitalKorea (Republic of) Innovations in Managing Advanced CKD Through Telemedicine VivekanandJha Speaker vjha@georgeinstitute.org.inGeorge Institute for Global Health IndiaIndia New Approaches to CKD Patient Education to Promote Uptake of PD and Home Hemodialysis Annie-ClaireNadeau-Fredette Speaker annieclairenaf@gmail.comUniversité de MontréalCanada A Shared Decision Process to Uptake of Conservative Management of Kidney Failure in the Elderly sunitaBavanandan Speaker sbavanandan@gmail.comHospital Kuala Lumpur, MalaysiaMalaysia Q and A Hall D
04:45 pm 05:30 pm	Implementing early CKD detection programs VivekanandJha Spotlight Speaker vjha@georgeinstitute.org.inGeorge Institute for Global Health IndiaIndia Jose VicenteSanchez Polo Spotlight Speaker visanpolo@gmail.comRenal Division Social Security Institute. Nephrology Residence Program Coordinator, San Carlos University School of Medicine. Latin-American Society Of Nephrology (SLANH)Guatemala LauraSola Spotlight Speaker solalaura11@gmail.comUruguay AdeeraLevin Spotlight Speaker alevin@providencehealth.bc.caCanada Spotlight Stage 1 (exhibition hall)

Day 3 - Tuesday April 16, 2024

Time	Session

09:00 am 10:00 am	Type 2 Diabetes in Kidney Disease: Recent Updates and Best Practices for Detection and Treatment DebasishBanerjee Chairperson dbanerje@sgul.ac.ukSt George's University Hospital NHS Foundation TrUnited Kingdom MegJardine Chairperson meg.jardine@sydney.edu.auNHMRC Clinical Trials Centre, University of Sydney, AustraliaAustralia Setting the Scene MegJardine Speaker meg.jardine@sydney.edu.auNHMRC Clinical Trials Centre, University of Sydney, AustraliaAustralia DM and CKD: Which Treatment Should I Use for Different Populations? KatherineTuttle Speaker Katherine.Tuttle@providence.orgUniversity of Washington, Department of NephrologyUnited States How to Design Studies on Answering Unanswered Questions VladoPerkovic Speaker vlado.perkovic@unsw.edu.auUniversity of New South Wales, Sydney, AustraliaAustralia The Effect of SGLT2 Inhibitors in Patients with Chronic Kidney Disease, With or Without Type 2 Diabetes DavidWheeler Speaker d.wheeler@ucl.ac.ukUniversity College LondonUnited Kingdom Q and A Hall C4
12:30 pm 01:30 pm	Hot Debate in CKD Hypertension Management: Targeting Systolic BP Below 120? MarkSarnak Chairperson msarnak@tuftsmedicalcenter.orgTufts Medical CenterUnited States MarceloOrías Chairperson marcelo.orias@gmail.comArgentina Hot Debate in CKD Hypertension Management: Targeting Systolic BP Below 120? - PROS TaraChang Speaker tichang@stanford.eduStanford UniversityUnited States Hot Debate in CKD Hypertension Management: Targeting Systolic BP Below 120? - CONS JordanaCohen Speaker jco@pennmedicine.upenn.eduUniversity of PennsylvaniaUnited States Hall A